INNOVATE Corp. receives NYSE delisting notice for sub-$1.00 average closing price

INNOVATE Corp.

NYSE notice on Feb. 26, 2024 for non-compliance with Section 802.01C (minimum share price).
Average closing price below $1.00 over 30 consecutive trading days.
No immediate delisting; six-month cure period to regain compliance.
Company to notify NYSE of intent to cure; evaluating all available options.
Failure to cure within six months will trigger suspension and delisting process.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.